DBV技術 DBVT 深 滬
交易中 10-28 11:16:04 美东时间
15.90
-0.090
-0.56%
華盛通- 最 高16.395
- 今 開15.93
- 成交量 4.43万股
- 最 低 15.76
- 昨 收 15.99
- 總市值 4.35亿
- 52周最高 18.00
- 市盈率 靜 --
- 換手率 0.16%
- 52周最低 2.2045
- 委 比 99.33%
- 總股本 2737.25万
- 歷史最高 505.70
- 量 比 0.94
- 振 幅 3.97%
- 歷史最低 3.15
- 每 手 1
- 風險率 3.44%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining more than 50 points ...
10-16 22:17
DBV Technologies announces $30 million ADS sale
DBV Technologies (NASDAQ:DBVT) announced on Monday that it has agreed to issue and sell new ordinary shares in the form of American Depositary Shares ((ADSs)) for total gross proceeds of $30 million t...
10-07 05:14
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies announced the sale of approximately $30 million of ADSs under its At-The-Market (ATM) Program on Nasdaq. The offering involved issuing 11,538,460 new ordinary shares (underlying 2,307,692 ADSs) at $13.00 per ADS, representing a 3.41% discount to the last closing price on Euronext Paris. The new shares will dilute existing shareholders by 7.77% and represent 8.42% of the existing shares on Euronext Paris. Invus, holding 13,857,460...
10-06 21:02
DBV Technologies Announces Board Member Resignation
DBV Technologies SA – American ( ($DBVT) ) has issued an update. On September 1...
09-19 04:56
IREN tops week's financial gainers, Circle Internet falls the most
This week's biggest movers among financial stocks included crypto-linked firms, fintechs and housing-related names. Overall, the Financial Select Sector SPDR ETF (XLF) dipped 1.5% in the past five ses...
09-06 22:10
DBV Technologies launches $150M ATM offering
DBV Technologies (NASDAQ:DBVT) filed a prospectus supplement with the SEC for an at-the-market offering up to $150M of American Depositary Shares. Each ADS represents five ordinary shares of the compa...
09-06 04:59
DBV Technologies Launches $150M At-The-Market Offering Program
DBV Technologies Establishes an At-The-Market (ATM) Program on NasdaqDBV Technologies (TRQX:DBVp) (the "Company"), a clinical-stage biopharmaceutical company, today announced that it has filed a prospectus supplement
09-06 04:34
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
DBV Technologies, a clinical-stage biopharmaceutical company, has announced the establishment of an at-the-market (ATM) program on the Nasdaq Capital Market, allowing it to offer and sell up to $150 million in American Depositary Shares (ADS). The proceeds will primarily support activities related to the Biologics License Application (BLA) for VIASKIN® Peanut patch in toddlers aged 1-3 years, as well as advance the development of other product ca...
09-05 20:30
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
DBV Technologies announced that CEO Daniel Tassé will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025. The event will be webcast live and available on the Company’s Investors website for 90 days. DBV is developing the VIASKIN® patch for treating food allergies through epicutaneous immunotherapy, targeting millions affected by this condition. The company focuses on clinical trials...
09-03 20:30
DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
DBV Technologies reported its Q2 2025 financial results, showing a net loss of $69.0 million for the first half of the year, compared to $60.5 million in 2024. Operating income decreased by $2.2 million due to reduced French research tax credits, while operating expenses rose by 7.5% due to increased R&D activities. The company raised $306.9 million in financing to advance its Viaskin Peanut patch, with $125.5 million received in April 2025. Cas...
07-29 20:08
